LAG3 and melanoma: Hemon et al. demonstrated that LAG-3 molecules protect MHC class II-positive melanoma cells from Fas-induced apoptosis by activating mitogen-activated protein kinase (MAPK)/Erk and PI3K/Akt pathways [85].